Decheng Capital Management III (Cayman)’s GeneDx Holdings WGS Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$377K	Hold	103,604	–	–	0.13%	25
2023 Q2	$617K	Hold	103,604	–	–	0.19%	24
2023 Q1	$1.25M	Hold	103,604	–	–	0.5%	21
2022 Q4	$903K	Hold	103,604	–	–	0.34%	22
2022 Q3	$3M	Hold	103,604	–	–	1.09%	20
2022 Q2	$4.31M	Hold	103,604	–	–	1.63%	15
2022 Q1	$10.5M	Buy	+103,604	New	+$11.5M	3.22%	11

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s WGS Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) held its GeneDx Holdings (WGS) position steady in Q3 2023 at 103,604 shares worth $377K. The position accounts for 0.13% of the portfolio, ranked #25.

Decheng Capital Management III (Cayman) first reported a position in WGS in Q1 2022 and has held it in 7 quarters since. The position peaked at $10.5M in Q1 2022. 53 funds tracked by Wall St. Rank hold WGS as of Q3 2023.

Decheng Capital Management III (Cayman) held 103,604 shares of GeneDx Holdings worth $377K as of Q3 2023.
Decheng Capital Management III (Cayman) left its GeneDx Holdings share count unchanged in Q3 2023.
GeneDx Holdings made up 0.13% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #25 holding.
Decheng Capital Management III (Cayman) first reported a position in GeneDx Holdings in Q1 2022 and has held it in 7 quarters since.
Decheng Capital Management III (Cayman)'s GeneDx Holdings position peaked at $10.5M in Q1 2022.
53 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.